SIOX NASDAQ
Sio Gene Therapies Inc.
1W: +22.9%
1M: +22.9%
3M: +21.0%
1Y: +4.9%
3Y: -83.5%
5Y: -94.9%
$0.48
Last traded 2024-02-07 — delisted
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
📊 Key Metrics
TTM$0M
Revenue
+0.0% YoY
$-28M
Net Income
+54.5% YoY
$-37M
Free Cash Flow
+29.7% YoY
0.0%
Gross Margin
0.0%
Op. Margin
0.0%
Net Margin
💰 Income Flow
How revenue becomes profit💵 Cash Flow
⚠️ Cash Burn Where cash goes🏦 Balance Sheet
Assets = Liabilities + Equity📈 Financial Health
Profitability
ROE-46.4%
ROA-40.1%
ROIC2320.3%
Valuation
P/E-0.5
P/B0.6
EV/EBITDA3.4
Leverage
Debt/Equity0.00
Current Ratio21.97
Interest Cov.-1628.6x
Quality Scores
Piotroski F3/9
Altman Z-24.97
Beneish M0.00